Literature DB >> 18831008

Ultrastructural and temporal changes of the microvascular basement membrane and astrocyte interface following focal cerebral ischemia.

Il Kwon1, Eun Hee Kim, Gregory J del Zoppo, Ji Hoe Heo.   

Abstract

Microvascular integrity is lost during cerebral ischemia. Detachment of the microvascular basement membrane (BM) from the astrocyte, as well as degradation of the BM, is responsible for the loss of microvascular integrity. However, their ultrastructural and temporal changes during cerebral ischemia are not well known. Male Sprague-Dawley rats were subjected to permanent middle cerebral artery occlusion (MCAO) for 1, 4, 8, 12, 16, 20, and 48 hr. By using transmission electron microscopy, the proportion of intact BM-astrocyte contacts and electron densities of the BM were measured from five randomly selected microvessels in the ischemic basal ganglia. Their temporal changes and associations with activities of the matrix metalloproteinases (MMPs) were investigated. The intact portion of the BM-astrocyte contacts was decreased significantly within 4 hr and was rarely observed at 48 hr after MCAO. Decreases in the electron density and degradation of the BM were significant 12 hr after MCAO. The intact BM-astrocyte contacts and the mean BM density showed a significant positive correlation (r = 0.784, P < 0.001). MMP-9 activity was correlated negatively with the intact BM-astrocyte contacts (r = -0.711, P < 0.001) and with the BM density (r = -0.538, P = 0.0016). The increase in MMP-9 coincided temporally with the loss of the BM-astrocyte contacts and a decrease in the BM density. Ultrastructural alterations occurring in the microvascular BM and its contacts with astrocyte endfeet were temporally associated in cerebral ischemia. Time courses of their alterations should be considered in the treatment targeted to the microvascular BM and its contact with astrocytes. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18831008      PMCID: PMC2711693          DOI: 10.1002/jnr.21877

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  26 in total

Review 1.  Mechanisms, challenges and opportunities in stroke.

Authors:  Eng H Lo; Turgay Dalkara; Michael A Moskowitz
Journal:  Nat Rev Neurosci       Date:  2003-05       Impact factor: 34.870

Review 2.  Neurovascular regulation in the normal brain and in Alzheimer's disease.

Authors:  Costantino Iadecola
Journal:  Nat Rev Neurosci       Date:  2004-05       Impact factor: 34.870

3.  A mitochondrial protein, Bit1, mediates apoptosis regulated by integrins and Groucho/TLE corepressors.

Authors:  Yiwen Jan; Michelle Matter; Jih-tung Pai; Yen-Liang Chen; Jan Pilch; Masanobu Komatsu; Edgar Ong; Minoru Fukuda; Erkki Ruoslahti
Journal:  Cell       Date:  2004-03-05       Impact factor: 41.582

4.  Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia.

Authors:  M Asahi; X Wang; T Mori; T Sumii; J C Jung; M A Moskowitz; M E Fini; E H Lo
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

5.  Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94.

Authors:  M Asahi; K Asahi; J C Jung; G J del Zoppo; M E Fini; E H Lo
Journal:  J Cereb Blood Flow Metab       Date:  2000-12       Impact factor: 6.200

6.  Microvascular basal lamina damage in thromboembolic stroke in a rat model.

Authors:  Milan R Vosko; Elmar Busch; Dorothe Burggraf; Gundula Bültemeier; Gerhard F Hamann
Journal:  Neurosci Lett       Date:  2003-12-26       Impact factor: 3.046

7.  Activation systems for latent matrix metalloproteinase-2 are upregulated immediately after focal cerebral ischemia.

Authors:  Dae-Il Chang; Naohisa Hosomi; Jacinta Lucero; Ji-Hoe Heo; Takeo Abumiya; Andrew P Mazar; Gregory J del Zoppo
Journal:  J Cereb Blood Flow Metab       Date:  2003-12       Impact factor: 6.200

8.  Focal cerebral ischemia induces active proteases that degrade microvascular matrix.

Authors:  Shunichi Fukuda; Catherine A Fini; Takuma Mabuchi; James A Koziol; Leonard L Eggleston; Gregory J del Zoppo
Journal:  Stroke       Date:  2004-03-04       Impact factor: 7.914

9.  Increase in plasma matrix metalloproteinase-9 in acute stroke patients with thrombolysis failure.

Authors:  Ji Hoe Heo; Seo Hyun Kim; Kyung Yul Lee; Eun Hee Kim; Chong Kyu Chu; Jeong Mo Nam
Journal:  Stroke       Date:  2003-05-15       Impact factor: 7.914

10.  Preconditioning with chronic cerebral hypoperfusion reduces a focal cerebral ischemic injury and increases apurinic/apyrimidinic endonuclease/redox factor-1 and matrix metalloproteinase-2 expression.

Authors:  Sun-Ah Choi; Eun Hee Kim; Jong Yun Lee; Hyo Suck Nam; Seo Hyun Kim; Gyung Whan Kim; Byung In Lee; Ji Hoe Heo
Journal:  Curr Neurovasc Res       Date:  2007-05       Impact factor: 1.990

View more
  38 in total

1.  Increased volumes of mildly elevated capillary transit time heterogeneity positively predict favorable outcome and negatively predict intracranial hemorrhage in acute ischemic stroke with large vessel occlusion.

Authors:  A Potreck; S Loebel; J Pfaff; L Østergaard; K Mouridsen; A Radbruch; M Bendszus; S Mundiyanapurath
Journal:  Eur Radiol       Date:  2019-03-18       Impact factor: 5.315

Review 2.  Roles of blood-brain barrier integrins and extracellular matrix in stroke.

Authors:  Danielle N Edwards; Gregory J Bix
Journal:  Am J Physiol Cell Physiol       Date:  2018-11-21       Impact factor: 4.249

3.  Basement membrane and stroke.

Authors:  Yao Yao
Journal:  J Cereb Blood Flow Metab       Date:  2018-09-18       Impact factor: 6.200

4.  Mean transit time on Aquilion ONE and its utilization in patients undergoing acute stroke intervention.

Authors:  Haitham Dababneh; Asif Bashir; Waldo R Guerrero; Kelvin Wilson; Mohammed Hussain; Sara Misthal; Walter Morgan; Keith Peters; Jawad F Kirmani; J Mocco
Journal:  J Vasc Interv Neurol       Date:  2014-12

Review 5.  Immunologic privilege in the central nervous system and the blood-brain barrier.

Authors:  Leslie L Muldoon; Jorge I Alvarez; David J Begley; Ruben J Boado; Gregory J Del Zoppo; Nancy D Doolittle; Britta Engelhardt; John M Hallenbeck; Russell R Lonser; John R Ohlfest; Alexandre Prat; Maurizio Scarpa; Richard J Smeyne; Lester R Drewes; Edward A Neuwelt
Journal:  J Cereb Blood Flow Metab       Date:  2012-10-17       Impact factor: 6.200

Review 6.  Aging and the neurovascular unit.

Authors:  Gregory J del Zoppo
Journal:  Ann N Y Acad Sci       Date:  2012-09       Impact factor: 5.691

Review 7.  Cell-specific blood-brain barrier regulation in health and disease: a focus on hypoxia.

Authors:  S Engelhardt; S Patkar; O O Ogunshola
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

8.  Compromised blood-brain barrier competence in remote brain areas in ischemic stroke rats at the chronic stage.

Authors:  Svitlana Garbuzova-Davis; Edward Haller; Stephanie N Williams; Eithan D Haim; Naoki Tajiri; Diana G Hernandez-Ontiveros; Aric Frisina-Deyo; Sean M Boffeli; Paul R Sanberg; Cesario V Borlongan
Journal:  J Comp Neurol       Date:  2014-09-01       Impact factor: 3.215

Review 9.  Monocyte chemoattractant protein-1 and the blood-brain barrier.

Authors:  Yao Yao; Stella E Tsirka
Journal:  Cell Mol Life Sci       Date:  2013-09-20       Impact factor: 9.261

10.  In the hypoxic central nervous system, endothelial cell proliferation is followed by astrocyte activation, proliferation, and increased expression of the alpha 6 beta 4 integrin and dystroglycan.

Authors:  Longxuan Li; Jennifer V Welser; Paula Dore-Duffy; Gregory J del Zoppo; Joseph C Lamanna; Richard Milner
Journal:  Glia       Date:  2010-08       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.